Skip to main content

Table 3 Diagnostic performance of IR surrogates for MACCE in the total population

From: Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus

 

AUC

Cut-off value

Sensitivity, %

Specificity, %

Est. (95% CI)

P-value

P for comparison

TyG index

0.715 (0.695–0.734)

< 0.001

–

8.85

81.28

53.13

VAI

0.673 (0.652–0.693)

< 0.001

0.001

2.20

75.40

49.84

CVAI

0.628 (0.607–0.649)

< 0.001

< 0.001

117.38

80.21

40.47

LAP

0.670 (0.650–0.691)

< 0.001

0.001

56.94

54.55

70.68

TG/HDL-C

0.651 (0.630–0.671)

< 0.001

< 0.001

3.02

81.82

40.94

  1. TyG triglyceride-glucose, VAI visceral adiposity index, CVAI Chinese visceral adiposity index, LAP lipid accumulation product, TG/HDL-C triglyceride-to-high density lipoprotein cholesterol ratio, AUC area under the ROC curve, CI confidence interval